Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01912339 · ClinicalTrials.gov registry record · NA
Safety and Efficacy Study for the Treatment of BPH (Enlarged Prostate)
A NA study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 197
- Enrollment target
NCT01912339 is a NA study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 197 participants.
The verdict
NCT01912339, a NA study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 197 participants
- Enrollment target
Study Summary
To evaluate the safety and efficacy of the Rezūm System and assess its effect on urinary symptoms secondary to benign prostatic hyperplasia (BPH).
Interventions
- DEVICE Rezum System
- PROCEDURE Rigid Cystoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 197 participants |
| Start Date | 2013-07 |
| Est. Completion | 2016-10-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01912339
The ClinicalTrials.gov registry entry for NCT01912339 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 197 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Rezum System is the first listed.
NCT01912339 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01912339 about?
NCT01912339 is a clinical study titled "Safety and Efficacy Study for the Treatment of BPH (Enlarged Prostate)". To evaluate the safety and efficacy of the Rezūm System and assess its effect on urinary symptoms secondary to benign prostatic hyperplasia (BPH).
What is the current status of trial NCT01912339?
This trial is currently completed. It is a NA study. The enrollment target is 197 participants. The study started on 2013-07. Estimated completion is 2016-10-17.
What interventions are being tested in trial NCT01912339?
The interventions under investigation include: Rezum System (DEVICE), Rigid Cystoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT01912339?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.